ISSN - 0973-0958

Pediatric Oncall Journal

Fitz-Hugh-Curtis Syndrome - an Unexpected Diagnosis and the Importance of Prevention 09/01/2020 00:00:00 https://www.pediatriconcall.com/Journal/images/journal_cover.jpg

Fitz-Hugh-Curtis Syndrome - an Unexpected Diagnosis and the Importance of Prevention

Filipa Urbano1, Catarina Marques Duarte1, Carla Simão2, Bárbara Matos Águas2, A. Siborro de Azevedo2.
1Department of Pediatrics, Santa Maria Hospital, Lisbon North Hospital and University Center, Lisbon, Portugal,
2General Pediatrics Unit of the Medical Pediatrics Service, Santa Maria Hospital, Lisbon North Hospital and University Center, Lisbon, Portugal.

ADDRESS FOR CORRESPONDENCE
Filipa Urbano, Departamento de Pediatria, do Hospital de Santa Maria, Avenida Professor, Egas Moniz, 1649-035, Lisboa, Portugal.
Email: filipaurbano.int@gmail.com
Abstract
Fitz-Hugh-Curtis Syndrome refers to perihepatitis associated with female genital tract infection. Chlamydia trachomatis and Neisseria gonorrhoeae are the main etiological agents. A 17-year-old female presented with right abdominal pain for five days, radiating to the right shoulder associated with fever, vomiting and diarrhea. Blood tests revealed raised levels of inflammatory markers, GGT, amylase and lipase. Abdominal ultrasonography showed no abnormality but abdominal and pelvic CT demonstrated perihepatitis. The adolescent reported the practice of unprotected sex and etiological investigation revealed N. gonorrhoeae and C. trachomatis in urethral and vaginal discharge respectively. These findings were suggestive of Fitz-Hugh-Curtis Syndrome. She was treated with azithromycin and ceftriaxone and had marked clinical improvement.
 
Keywords
adolescent, abdominal pain, pelvic inflammatory disease, sexually transmitted diseases, Fitz-Hugh-Curtis Syndrome
 
Introduction
The normal adolescent psychosocial development leads to a desire for autonomy and risky behaviors.1 Besides, adolescents rarely seek health care, being vulnerable to sexually transmitted infections (STI).2 Chlamydia trachomatis and Neisseria gonorrhoeae, the main bacterial causes, rarely lead to complications if treated early.2,3,4,5,6 On the other hand, failure to treat these infections could lead to complications such as pelvic inflammatory disease (PID), epididymitis, orchitis, infertility and cervical, penile or anal cancer.3 PID is an acute or subclinical infection of the upper female genital tract resulting from an upward contamination of endocervicitis.3,6 Risk factors are age under 25 years old, sexual activity particularly with new or multiple sexual partners, personal history of STI or PID, partner with STI, consumption of alcohol, tobacco or other drugs and pelvic or uterine instrumentation.6,7,8 The use of barrier contraceptive methods is a protective factor.8 Although not pathognomonic, clinical signs have a sensitivity of 65-90% for the diagnosis of the disease, which could present with abdominal or pelvic pain, dyspareunia, vaginal discharge, metrorrhagia, fever, vomiting or pain on cervical and adnexal mobilization.6,7,9 A positive result for C. trachomatis and Mycoplasma genitalium in the urethral or vaginal biological fluids supports the diagnosis, while the absence of vaginal discharge has an important negative predictive value.7,8 To exclude other pathologies or complications, abdominal and pelvic ultrasound, CT or MRI may be indicated.6,7,9 Antibiotic therapy should be started early and empirically, with broad spectrum associations, combined with sexual partners’ treatment and safe sex practices.6,7
The unpredictable evolution of STI may be associated with acute or chronic complications.6,7 Fitz-Hugh-Curtis Syndrome (FHCS) is a complication of PID, occurring in 4-27% of the cases.3,10 It is characterized by perihepatitis, with pleuritic pain in the right hypochondrium, sometimes radiating to the right shoulder.7,9,10 The definitive diagnosis is made by laparoscopy or laparotomy, showing violin-string liver adhesions and the presence of microorganisms in the liver capsule.9,10 However, the recommended procedures are the non-invasive ones, since the disease is benign, treatable with targeted antibiotic therapy and the benefits of the hepatic adhesions treatment is not demonstrated.7,10 The hepatic enhancement that appears on CT suggests the diagnosis.10 We present a 17 years old female who had perihepatitis and N. gonorrhoeae and C. trachomatis in urethral and vaginal discharge respectively.
 
Case Report
A 17-years-old adolescent, with no relevant personal history, presented with fever, vomiting, diarrhea and constant abdominal pain. On the fifth day of the disease, she went to an emergency service where the blood tests (Table 1) revealed an increase in inflammatory parameters (white blood cells 22.1x109/L with 88.1% of neutrophils and C reactive protein 12.3 mg/dL), GGT (79 U/L), amylase (134 U/L) and lipase (85 U/L), with normal liver function tests and a negative immunological test for pregnancy. Abdominal ultrasound was normal. She was transferred to our hospital for pediatric surgery. At our hospital, she was apyretic, sometimes tachycardic but always hemodynamically stable, with periods of severe abdominal pain. Evaluation by pediatric surgeon found a decrease in the bowel sounds; right iliac fossa and right hypochondrium pain on palpation; abdominal muscle contracture and a positive Murphy and Psoas signs. The blood test results were like the previous ones. Chest radiography and abdominal ultrasound showed no relevant changes. Abdominal and pelvic CT showed perihepatitis (Figure 1) and an inflammatory process of the fallopian tubes. The patient reported regular unprotected sex with more than one partner. Integrating the clinical history with the examination findings, the diagnostic hypothesis was PID complicated by perihepatitis and FHCS. Gynecology evaluation was unremarkable. Culture of urethral discharge was positive for N. gonorrhoeae, PCRs for C. trachomatis and Mycoplasma hominis were positive on vaginal discharge. Other STIs (HIV, syphilis, hepatitis B and C and herpes simplex virus 1 and 2 infections) were excluded. She was treated with a single dose of intramuscular ceftriaxone 500 mg plus a single dose of oral azithromycin 1g, followed by a second dose of oral azithromycin 1g one week later. Sexual contacts screening for the last three months was recommended. Diagnosis of gonorrhea in a sexual partner was confirmed a month later follow up visit.

Figure 1. Peripheral hyperdensities of the liver (arrows), compatible with perihepatitis, on abdominal and pelvic CT.
<b>Figure 1.</b> Peripheral hyperdensities of the liver (arrows), compatible with perihepatitis, on abdominal and pelvic CT.

 
Discussion
Sexually active adolescents have a higher incidence of STI than adult women2 and an age appropriate clinical history is crucial for the diagnosis of these infections. FHCS should be considered in the differential diagnosis of young people with right hypochondrium pain.9,10 In this case report, the visualization of peri-hepatitis on CT scan reinforced the diagnostic hypothesis and was confirmed by microbiological diagnosis.
The treatment of N. gonorrhoeae infections should also involve eradication of C. trachomatis, whose concomitant infection is relatively common.12 The combination antimicrobial therapy with extended-spectrum cephalosporins and azithromycin seems to show synergy in-vitro and in-vivo so, the recommended empirical treatment is intramuscular ceftriaxone 500 mg with oral azithromycin 1 g, and another 1 g one week later.12
The risk of infertility, chronic pelvic pain and extrauterine pregnancy increases with each episode of PID.7 Nevertheless, if appropriate antimicrobial therapy is implemented early, fertility is usually preserved after the first episode of PID.7 It is therefore important that, in an opportunistic way, adolescents are informed of the risk factors for these diseases, namely unprotected sexual activity with multiple partners.6,7,8 In patients undergoing therapy, it is crucial to inform that they should avoid unsafe sex practices until the treatment is complete and symptoms resolved and that sexual contacts should be screened for the infection as well.3,7 Informing the population is one of the main steps for a healthy population.
 
Compliance with Ethical Standards
Funding None
 
Conflict of Interest None
 
  1. UpToDate. Sexually transmitted infections: Issues specific to adolescents. Available at URL: https://www.uptodate.com/contents/ sexually-transmitted-infections-issues-specific-to-adolescents?search=sexual%20infections%20diseases& source=search_result&selectedTitle=2~150& usage_type=default&display_rank=2. Accessed on 12 February 2019.
  2. Inquérito Serológico Nacional 2015-2016: Infeções Sexualmente Transmissíveis. Outubro de 2017. Available at URL: http://repositorio.insa.pt/bitstream/ 10400.18/5402/1/INSA_ISN-2015-2016-IST_web.pdf. Accessed on 1st December 2020.
  3. Grupo para o Estudo e Investigação de Doenças Sexualmente Transmissíveis da Sociedade Portuguesa de Dermatovenereologia. Infecções Sexualmente Transmissíveis - IST. 2017. Available at URL: https://www.spdv.pt/op/document/?co=209&h=f413e&in=1. Accessed on 1st December 2020.
  4. Grupo para o Estudo e Investigação de Doenças Sexualmente Transmissíveis da Sociedade Portuguesa de Dermatovenereologia. Infeção genital por Clamídia. 2017. Available at URL: https://www.spdv.pt/op/document/?co=216&h=7e6a8&in=1. Accessed on 1st December 2020.
  5. Grupo para o Estudo e Investigação de Doenças Sexualmente Transmissíveis da Sociedade Portuguesa de Dermatovenereologia. Gonorreia. 2017. Availbale at URL: https://www.spdv.pt/op/document/?co=215&h=45be3&in=1. Accessed on 1st December 2020.
  6. Sociedade Portuguesa de Ginecologia. Consenso sobre Infecções Sexualmente Transmissíveis: Endocervicites e DIPs. 2007. Available at URL: https://www.spdv.pt/_grupo_para_o_estudo_e _investigacao_das_doencas_sexualmente _transmissiveis/. Accessed on 1st December 2020.
  7. Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29:108-114.  [CrossRef]  [PubMed]
  8. UpToDate. Pelvic inflammatory disease: Pathogenesis, microbiology, and risk factors. Available at URL: https://www.uptodate.com/contents/pelvic-inflammatory-disease-pathogenesis-microbiology-and-risk-factors?search=pelvic%20inflammatory%20disease& source=search_result&selectedTitle=3~150& usage_type=default&display_rank=3. Accessed on 12th February 2019.
  9. UpToDate. Pelvic inflammatory disease: Clinical manifestations and diagnosis. Available at URL: https://www.uptodate.com/contents/pelvic-inflammatory-disease-clinical-manifestations-and-diagnosis?search=pelvic%20inflammatory%20disease& source=search_result&selectedTitle=2~150& usage_type=default&display_rank=2. Accessed on 12th February 2019.
  10. You JS, Kim MJ, Chung HS, Chung YE, Park I, Chung SP, et al. Clinical Features of Fitz-Hugh-Curtis Syndrome in the Emergency Department. Yonsei Med J. 2012;53:753-758.  [CrossRef]  [PubMed]  [PMC free article]
  11. Smith S. Sexually Transmitted Infections. In: Marcdante KJ, Kliegman RM (Eds). Nelson Essentials of Pediatrics. 7th ed. Elsevier Saunders. 2015:376-381.
  12. Bignell C, Unemo M. 2012 European Guideloine on the Diagnosis and Treatment of Gonorrhoea in Adults.Int J STD AIDS. 2009;20:453-457.  [CrossRef]  [PubMed]



DOI: https://doi.org/10.7199/ped.oncall.2021.17

Cite this article as:
Urbano F, Duarte C M, Simão C, Águas B M, Azevedo A S d. Fitz-Hugh-Curtis Syndrome - an Unexpected Diagnosis and the Importance of Prevention. Pediatr Oncall J. 2021;18: 53-55. doi: 10.7199/ped.oncall.2021.17
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0